Dystonia, typically characterized by slow repetitive involuntary movements, stiff abnormal
postures, and hypertonia, is common among individuals with cerebral palsy (CP). Dystonia …

Cannabis is one of the oldest and widely used substances in the world. Cannabinoids within
the cannabis plant, known as phytocannabinoids, mediate cannabis' effects through …

Background Spasticity affects 54% of multiple sclerosis (MS) patients at disease onset, but
this rate gradually increases with disease progression. Spasticity does not fully respond to …

Aim To assess the efficacy, safety, and tolerability of oromucosal nabiximols cannabinoid
medicine as adjunct therapy for children with spasticity due to cerebral palsy/traumatic …

Aim Evaluation of cannabinoid receptor agonists in a preclinical model of medication
overuse headache. Methods Female Sprague Dawley rats received graded intraperitoneal …

Background: As far as 80% of people diagnosed with multiple sclerosis (MS) experience
disabling symptoms in the course of the disease, such as spasticity and neuropathic pain. As …

Aim To identify research priorities regarding the effectiveness of interventions for children
and young people (CYP) with childhood neurological conditions (CNCs). These include …

Background In the late nineteenth and early twentieth centuries, cannabis in the United
States was mostly restricted to medical use, including for the management of pain …

Many of us have a layman's understanding of spasticity as being stiff and tight, but the
clinical definition is much more complicated. We hear the terms low tone, high tone …

The enduring relationship between humanity and the cannabis plant has witnessed
significant transformations, particularly with the widespread legalization of medical …